Suffocating cancer cells
Self-assembling molecules could help in cancer therapy
- Date:
- September 8, 2022
- Source:
- Max Planck Institute for Polymer Research
- Summary:
- Development of medical treatment against cancer is a major research topic worldwide -- but cancer often manages to circumvent the solutions found. Scientists have now taken a closer look at the cancer's countermeasures and aim to stop them. By disrupting the cellular components that are responsible for converting oxygen into chemical energy, they have demonstrated initial success in eliminating cells derived from untreatable metastatic cancer.
- Share:
Development of medical treatment against cancer is a major research topic worldwide -- but cancer often manages to circumvent the solutions found. Scientists around Tanja Weil and David Ng at the Max Planck Institute for Polymer Research (MPI-P), have now taken a closer look at the cancer's countermeasures and aim to stop them. By disrupting the cellular components that are responsible for converting oxygen into chemical energy, they have demonstrated initial success in eliminating cells derived from untreatable metastatic cancer.
Treatment of cancer is a long-term process because remnants of living cancer cells often evolve into aggressive forms and become untreatable. Hence, treatment plans often involve multiple drug combinations and/or radiation therapy in order to prevent cancer relapse. To combat the variety of cancer cell types, modern drugs have been developed to target specific biochemical processes that are unique within each cell type.
However, cancer cells are highly adaptive and able to develop mechanisms to avoid the effects of the treatment. "We want to prevent such adaptation by invading the main pillar of cellular life -- how cells breathe -- that means take up oxygen -- and thus produce chemical energy for growth," says David Ng, group leader at the MPI-P.
The research team produced a synthetic drug that travels into cells where it reacts to conditions found inside and triggers a chemical process. This allows the drug's molecules to bind together and form tiny hairs that are a thousand times thinner than human hair. "These hairs are fluorescent, so you can look at them directly with a microscope as they form," says Zhixuan Zhou, an Alexander-von-Humboldt-fellow and first author of the paper.
The scientists monitored the oxygen consumption in different cell types and found that the hairs stop all of them from converting oxygen into ATP, a molecule that is responsible for energy delivery in cells. The process worked even for those cells derived from untreatable metastatic cancer. As a result, the cells die rapidly within four hours. After some more years of research, the scientists hope that they can develop a new method to treat up-to-now untreatable cancer.
Weil, Ng and colleagues have shown an exciting outcome under controlled laboratory culture and will continue to unravel deeper insights on the basis of how these tiny hairs prevent the conversion of oxygen to chemical energy. With further development, these objects could in the future possibly also be manipulated to control other cellular processes to address other important diseases.
They have published their results in the Journal of the American Chemical Society.
Story Source:
Materials provided by Max Planck Institute for Polymer Research. Note: Content may be edited for style and length.
Journal Reference:
- Zhixuan Zhou, Konrad Maxeiner, Pierpaolo Moscariello, Siyuan Xiang, Yingke Wu, Yong Ren, Colette J. Whitfield, Lujuan Xu, Anke Kaltbeitzel, Shen Han, David Mücke, Haoyuan Qi, Manfred Wagner, Ute Kaiser, Katharina Landfester, Ingo Lieberwirth, David Y.W. Ng, Tanja Weil. In Situ Assembly of Platinum(II)-Metallopeptide Nanostructures Disrupts Energy Homeostasis and Cellular Metabolism. Journal of the American Chemical Society, 2022; 144 (27): 12219 DOI: 10.1021/jacs.2c03215
Cite This Page: